1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-03-01 Sage Accounts Production Advanced 2023 - FRS102_2023 483,316 32,174 81,138 285,515 148,837 148,837 483,316 xbrli:pure xbrli:shares iso4217:GBP 07938081 2023-03-01 2024-02-27 07938081 2024-02-27 07938081 2023-02-28 07938081 2022-03-01 2023-02-28 07938081 2023-02-28 07938081 2022-02-28 07938081 bus:Director1 2023-03-01 2024-02-27 07938081 core:WithinOneYear 2024-02-27 07938081 core:WithinOneYear 2023-02-28 07938081 core:ShareCapital 2024-02-27 07938081 core:ShareCapital 2023-02-28 07938081 core:SharePremium 2024-02-27 07938081 core:SharePremium 2023-02-28 07938081 core:RetainedEarningsAccumulatedLosses 2024-02-27 07938081 core:RetainedEarningsAccumulatedLosses 2023-02-28 07938081 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 07938081 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-02-27 07938081 core:DisposalsRepaymentsInvestments core:Non-currentFinancialInstruments 2024-02-27 07938081 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-02-27 07938081 core:CostValuation core:Non-currentFinancialInstruments 2024-02-27 07938081 core:Non-currentFinancialInstruments 2024-02-27 07938081 core:Non-currentFinancialInstruments 2023-02-28 07938081 bus:Director1 2023-02-28 07938081 bus:Director1 2024-02-27 07938081 bus:Director1 2022-02-28 07938081 bus:Director1 2023-02-28 07938081 bus:Director1 2022-03-01 2023-02-28 07938081 bus:SmallEntities 2023-03-01 2024-02-27 07938081 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-27 07938081 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-27 07938081 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-27 07938081 bus:FullAccounts 2023-03-01 2024-02-27
COMPANY REGISTRATION NUMBER: 07938081
Sallou Limited
Filleted Unaudited Financial Statements
27 February 2024
Sallou Limited
Financial Statements
Period from 1 March 2023 to 27 February 2024
Contents
Page
Statement of financial position
1
Notes to the financial statements
3
Sallou Limited
Statement of Financial Position
27 February 2024
27 Feb 24
28 Feb 23
Note
£
£
Fixed assets
Investments
5
148,837
483,316
Current assets
Debtors
6
18,142
39,444
Cash at bank and in hand
24
1,834
--------
--------
18,166
41,278
Creditors: amounts falling due within one year
7
77,206
85,327
--------
--------
Net current liabilities
59,040
44,049
---------
---------
Total assets less current liabilities
89,797
439,267
--------
---------
Net assets
89,797
439,267
--------
---------
Capital and reserves
Called up share capital
400
400
Share premium account
24,900
24,900
Profit and loss account
64,497
413,967
--------
---------
Shareholders funds
89,797
439,267
--------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the period ending 27 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Sallou Limited
Statement of Financial Position (continued)
27 February 2024
These financial statements were approved by the board of directors and authorised for issue on 12 November 2024 , and are signed on behalf of the board by:
Mr B G Adams
Director
Company registration number: 07938081
Sallou Limited
Notes to the Financial Statements
Period from 1 March 2023 to 27 February 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 64 Brewery Road, Woking, Surrey, GU21 4QH.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 1 (2023: 1 ).
5. Investments
Other investments other than loans
£
Cost
At 1 March 2023
483,316
Additions
32,174
Disposals
( 81,138)
Revaluations
( 285,515)
---------
At 27 February 2024
148,837
---------
Impairment
At 1 March 2023 and 27 February 2024
---------
Carrying amount
At 27 February 2024
148,837
---------
At 28 February 2023
483,316
---------
6. Debtors
27 Feb 24
28 Feb 23
£
£
Other debtors
18,142
39,444
--------
--------
7. Creditors: amounts falling due within one year
27 Feb 24
28 Feb 23
£
£
Corporation tax
75,729
84,570
Other creditors
1,477
757
--------
--------
77,206
85,327
--------
--------
8. Director's advances, credits and guarantees
During the period the director entered into the following advances and credits with the company:
27 Feb 24
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Mr B G Adams
32,897
( 19,333)
13,564
--------
--------
--------
28 Feb 23
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Mr B G Adams
50,201
( 17,304)
32,897
--------
--------
--------